Packaging for Semaglutide 2.4 mg

Novo Nordisk A/S

Packaging for Semaglutide 2.4 mg by Novo Nordisk A/S

Description

The packaging material for Semaglutide 2.4 mg, including the carton box and partition board.

This certificate covers the following products:

Included: Secondary paperboard packaging including carton and partition board. Excluded: Leaflets and pen-injector.

This product has been certified according to the Version 4.0 Draft 1 requirements for General Requirements, Material Health, Clean Air & Climate Protection, and Social Fairness. It has been certified according to the Version 4.0 Draft 2 requirements for Product Circularity and Water & Soil Stewardship.

As a result of travel restrictions due to COVID 19, no site visit could be conducted. This certificate has been issued on a provisional basis.

Sourcing information: The two final manufacturing facilities and all tier 1 suppliers to final manufacturing are located in the United States.

PLEASE NOTE: The description of the product is provided solely by the product’s manufacturer. C2CPII cannot and does not independently verify the accuracy of the product description in this registry, and only attests to the validity and level of certification awarded to each product under the Cradle to Cradle Certified Product Standard. Please contact the product’s manufacturer with any questions about the product’s description or purchasing details.